Privately-owed French pharmaceutical company, Pierre Fabre SA, has licensed exclusive rights to Abbott Laboratories to a preclinical monoclonal antibody for cancer that targets a membrane receptor known as c-Met. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
